Second-generation double antibody protects from SARS-CoV-2 and its tested variants
Second-generation double antibody protects from SARS-CoV-2 and its tested variants The Institute for Research in Biomedicine (IRB; Bellinzona, Switzerland), affiliated to the Università della Svizzera italiana (USI) developed a second-generation 'double antibody' that protects from SARS-CoV-2, the virus causing COVID-19, and all its tested variants. It also prevents the virus from mutating to resist the therapy . Antibody-based immunotherapy was already shown to be effective against COVID-19 but faces two main obstacles: it needs to work against the circulating viral variants; it must preven...
Source: news-medical.net